Clinical variables | OR | 95% CI | P-value |
---|---|---|---|
Model 1 | |||
TIMI risk score | 1.22 | 1.07,1.40 | 0.004 |
MELD-XI | 1.09 | 1.04,1.14 | 0.001 |
log(creatine kinase MB) | 1.44 | 0.79,2.61 | 0.236 |
ALT > 40 U/L | 1.48 | 0.68,3.20 | 0.326 |
LVEF | 0.98 | 0.96,1.01 | 0.178 |
IABP | 3.69 | 1.85,7.36 | < 0.001 |
Model 2 | |||
TIMI risk score | 1.23 | 1.07,1.41 | 0.003 |
MELD-XI ≥ 13 | 3.83 | 1.99,7.40 | < 0.001 |
log(creatine kinase MB) | 1.63 | 0.88,3.01 | 0.122 |
ALT > 40 U/L | 1.28 | 0.59,2.76 | 0.527 |
LVEF | 0.98 | 0.96,1.01 | 0.226 |
IABP | 3.59 | 1.79,7.19 | < 0.001 |